IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,692,000 | +1.3% | 82,126 | +27.4% | 0.00% | 0.0% |
| Q4 2020 | $3,644,000 | +59.7% | 64,457 | +34.0% | 0.00% | +50.0% |
| Q3 2020 | $2,282,000 | +12.5% | 48,085 | +39.8% | 0.00% | 0.0% |
| Q2 2020 | $2,028,000 | +58.3% | 34,403 | +27.1% | 0.00% | 0.0% |
| Q1 2020 | $1,281,000 | -40.6% | 27,065 | -24.2% | 0.00% | -33.3% |
| Q4 2019 | $2,156,000 | +0.8% | 35,689 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,138,000 | +8.6% | 35,689 | +16.5% | 0.00% | +50.0% |
| Q2 2019 | $1,968,000 | – | 30,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |